Stock Analysis

LANXESS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

XTRA:LXS
Source: Shutterstock

LANXESS (ETR:LXS) Third Quarter 2024 Results

Key Financial Results

  • Revenue: €1.60b (flat on 3Q 2023).
  • Net income: €1.00m (up from €131.0m loss in 3Q 2023).
  • Profit margin: 0.1% (up from net loss in 3Q 2023).
  • EPS: €0.01 (up from €1.52 loss in 3Q 2023).
earnings-and-revenue-growth
XTRA:LXS Earnings and Revenue Growth November 9th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

LANXESS EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) exceeded analyst estimates.

Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.

Performance of the German Chemicals industry.

The company's shares are down 12% from a week ago.

Risk Analysis

Be aware that LANXESS is showing 1 warning sign in our investment analysis that you should know about...

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:LXS

LANXESS

Operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide.

Undervalued with moderate growth potential.